The global asthma devices market is likely to grow at a 4.3% CAGR between 2017- 2023, according to the recent Market Research Future (MRFR) report. Asthma inhalers, simply put, are medical devices that deliver medication to the body through the lungs, thus treating chronic obstructive pulmonary disease and asthma.
On the contrary, lack of favorable reimbursement policies, low per capita income, long treatment procedures are factors that may limit the asthma devices market growth over the forecast period.
The MRFR report provides an inclusive segmental analysis of the global asthma devices market based on end users, technology, and type.
By type, the global asthma devices market is segmented into nebulizers, inhalers, and others. The inhalers segment is again segmented into dry powder inhalers and metered-dose inhalers. The metered-dose inhalers are again segmented into metered-dose inhalers with a spacer, breath-activated pressurized metered-dose inhalers, standard pressurized metered-dose inhalers, and others. The nebulizers segment is again segmented into mesh nebulizers, ultrasonic nebulizers, compressor nebulizers, and others.
By technology, the global asthma devices market is segmented into digitally operated inhaler devices, manually operated inhaler devices, and others.
By end users, the global asthma devices market is segmented into retail pharmacies, clinics, and hospitals, and others.
Based on the region, the global asthma devices market report covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will lead the market over the forecast period for the huge patient population having asthma and the presence of a well-developed healthcare sector. Besides, the presence of key players, increasing healthcare expenditure, and changing lifestyles are also adding market growth in the region.
The global asthma devices market in Europe is predicted to have the second-largest share over the forecast period. Factors fuelling market growth include a huge patient population, the presence of well-developed healthcare infrastructure, rising healthcare expenditure, and support from the government for research development. Besides, the presence of developed economies such as France, Germany, and the UK are also adding market growth in the region.
The global asthma devices market in the APAC region is predicted to grow at a quick pace over the forecast period for the constantly developing economies such as China and India, huge patient population, growing healthcare sector in India, and favorable government policies such as reduced customs duty and excise followed by exemptions in service tax. The Indian healthcare sector is predicted to touch USD 280 billion at a 22.8% CAGR by 2020.
The global asthma devices market in the MEA is predicted to have the smallest share over the forecast period for the presence of a poor economy in the African region. Besides, stringent government policies and the absence of a developed healthcare sector are also restraining market growth. The Middle East region will have a favorable share for the huge healthcare expenditures.
Eminent players profiled in the global asthma devices market report include Koninklijke Philips N.V. (Europe), Boehringer Ingelheim GmbH (Europe), Baxter. (U.S.), AstraZeneca (Europe), SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific), Aristopharma Ltd. (Asia Pacific), 3M (U.S.), Merck Co., Inc. (U.S.), and GlaxoSmithKline plc. (Europe). Industry players have incorporated strategies such as mergers, acquisitions, joint ventures and collaborations, new product development and new product launches, research and development, geographic expansions, and contracts to create a niche in the market.